The U.S. Nuclear Regulatory Commission is in the process of rescinding or revising guidance and policies posted on this webpage in accordance with Executive Order 14151 Ending Radical and Wasteful Government DEI Programs and Preferencing, and Executive Order 14168 Defending Women From Gender Ideology Extremism and Restoring Biological Truth to the Federal Government. In the interim, any previously issued diversity, equity, inclusion, or gender-related guidance on this webpage should be considered rescinded that is inconsistent with these Executive Orders.

Commission Meeting: Briefing on Potential Medical Isotope Production Licensing Actions

Federal Agency Representative:
Parrish Staples, DOE/NNSA

Potential Producer Representatives:
Randy Spickard, Babcock and Wilcox
Carmen I. Bigles, Coqui Radiopharmaceuticals Corp.
Gregory Piefer, SHINE Medical Technologies, Inc.

NRC Staff Presentation

Page Last Reviewed/Updated Friday, February 10, 2017